Ragaglitazar | Interleukin Related interleukin-related.com

Product Name :
Ragaglitazar

Search keywords :
Ragaglitazar

drugId :
null

Target Vo:
Peroxisome proliferator-activated receptor γ

Target Vo Short Name :
PPARγ

Moa_Name:
Peroxisome proliferator-activated receptor γ agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Novo Nordisk A/S

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Diabetes Mellitus, Type 2

Termination Status :
Phase 3 Clinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
FOXA2 Antibody MedChemExpress
Andecaliximab custom synthesis
RHEB Antibody: RHEB Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 20 kDa, targeting to RHEB. It can be used for WB,ICC,IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts